Dr Jackson Thomas (BPharm, MPharmSc, PhD) is a pharmacist, trialist, NHMRC-funded pharmaceutical scientist, and Associate Professor at the University of Canberra. Jackson also serves as a consultant for pharmaceutical manufacturers, biotech companies, and the Therapeutic Goods Administration (TGA). Prior to his appointment at UC in 2013, he held academic/research positions at University of Tasmania and Charles Darwin University (2004-2012).

Jackson has a specific clinical and research interest in indigenous child health, especially skin infections in Australian Indigenous children. Other research interests include (but are not limited to) global health (drug stability and counterfeit medications), dermatological conditions, discovery of bio-actives from natural resources, complementary and alternative medicine, and innovations in teaching. As a result of his research achievements, he was given the 2015 ACT Tall Poppy of the Year Award. Following on from this, he was selected into the Early- and Mid-Career Research Forum Executive Committee affiliated to Australian Academy of Science and a specialist advisor for Therapeutic Goods Administration (TGA).

Jackson's research group currently conducts pharmaceutical studies (including product formulation and stability trials), clinical and preclinical toxicological studies and animal and human clinical trials.

Jackson's recent contributions in the field of tropical infectious diseases have been recognised by several awards:

• 2018: UC Finalist for the VC’s Early Career Researcher of the Year Award
• 2018: UC Commendation for Distinction in Engagement
• 2018: UC Research Excellence Award (ECR category)
• 2017: Faculty of Health Research Impact Award
• 2015: ARC nomination to represent Australia at Global Young Scientists Summit, Singapore
• 2014: ACT Young Tall Poppy Award (Australian Institute of Policy & Science)

Google Scholar Profile 

Our team is actively looking to recruit